05/14/2024
5:42 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2024
6:01 AM | Syros Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2024
6:05 AM | Syros Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
6:10 AM | Syros Pharmaceuticals (Filer)
| Form ARS | |
04/12/2024
3:30 PM | Syros Pharmaceuticals (Filer)
| Form PRE 14A | |
04/05/2024
3:30 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:54 PM | Haas Jason (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/02/2024
3:57 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:58 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:59 PM | Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:01 PM | Stephens Kristin (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:14 PM | Roth David (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
6:04 AM | Syros Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024
5:49 AM | Syros Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:56 PM | Blue Owl Capital Holdings LP (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G | |
02/13/2024
7:22 PM | Avidity Partners Management LP (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
5:59 PM | Bain Capital Life Sciences Fund II, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
6:02 PM | Ally Bridge MedAlpha Master Fund L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
4:08 PM | Artal International S.C.A. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/07/2024
6:09 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/08/2024
6:06 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
3:15 PM | Point72 Asset Management, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G | |
12/26/2023
4:19 PM | Samsara BioCapital, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/26/2023
4:24 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:53 PM | Syros Pharmaceuticals (Filer)
| Form 424B5 | |
12/19/2023
3:59 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
3:24 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:12 PM | Roth David (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
3:23 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
6:05 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
4:23 PM | Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:28 PM | Chee Conley (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
5:47 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
3:51 PM | Chee Conley (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:52 PM | Stephens Kristin (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:52 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/20/2023
3:15 PM | Samsara BioCapital, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13D | |
10/20/2023
3:23 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
7:49 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:46 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:47 PM | Alles Mark J (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
This military-backed stock “owns” AI market (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
09/19/2023
3:48 PM | Syros Pharmaceuticals (Issuer)
Young Richard A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:05 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
5:53 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
3:12 PM | Roth David (Reporting)
Syros Pharmaceuticals (Subject)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/21/2023
3:36 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
7:27 PM | Olson Eric R (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
3:00 PM | Olson Eric R (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
